|
KATNA1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62581059726108E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.01096908622367E-12 |
| Normal-vs-Stage2 |
6.72739997042981E-09 |
| Normal-vs-Stage3 |
1.84741111297626E-13 |
| Normal-vs-Stage4 |
1.65811808727767E-12 |
| Stage1-vs-Stage2 |
4.065600E-01 |
| Stage1-vs-Stage3 |
1.078220E-01 |
| Stage1-vs-Stage4 |
3.165700E-02 |
| Stage2-vs-Stage3 |
7.598000E-01 |
| Stage2-vs-Stage4 |
3.290400E-01 |
| Stage3-vs-Stage4 |
4.061400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.55111512312578E-16 |
| Normal-vs-AfricanAmerican |
4.08649999994459E-06 |
| Normal-vs-Asian |
9.20299999984664E-07 |
| Caucasian-vs-AfricanAmerican |
2.664600E-01 |
| Caucasian-vs-Asian |
3.708200E-02 |
| AfricanAmerican-vs-Asian |
6.749000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.99200722162641E-16 |
| Normal-vs-Female |
1.7027490528676E-12 |
| Male-vs-Female |
3.453900E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.68940417211161E-11 |
| Normal-vs-Age(41-60Yrs) |
1.69597669241739E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62470037423645E-12 |
| Normal-vs-Age(81-100Yrs) |
7.78330000006378E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.342800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.100000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.183040E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.367900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.069200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.211400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.264400E-02 |
| Classical-VS-Follicular |
1.263520E-02 |
| Classical-VS-Other |
3.147200E-01 |
| Classical-VS-Normal |
1.80222503587402E-12 |
| Tall-VS-Follicular |
8.572000E-01 |
| Tall-VS-Other |
9.215200E-01 |
| Tall-VS-Normal |
2.87240231600094E-11 |
| Follicular-VS-Other |
9.723800E-01 |
| Follicular-VS-Normal |
2.3125945602942E-12 |
| Other-VS-Normal |
3.610100E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.53210777398272E-14 |
| Normal-vs-N1 |
9.51461132103759E-14 |
| N0-vs-N1 |
5.502000E-02 |
|
|
